Blais, Joseph E

Psychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study

Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry

Mental Health Treatment and AccessPharmaceutical Economics and Policy

Cited by 203

Overall and sex-specific effect of berberine for dyslipidemia: systematic review and meta-analysis of placebo-controlled trials

Blais, J. E., Huang, X., & Zhao, J. V. (2022) · medRxiv

Berberine and alkaloids researchLipoproteins and Cardiovascular Health

Cited by 31

Trends in PCSK9 inhibitor utilization in the United States, Europe, and other countries: An analysis of international sales data

Blais, J. E., Wei, Y., Knapp, M., Wong, I. C. K., Wei, L., & Chan, E. W. (2022) · American Heart Journal

Lipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy

Cited by 16

Adherence to PCSK9 Inhibitors in Clinical Practice

Blais, J. E., Zhong, W., Li, C. Y. V., Kongkaew, C., & Chan, A. H. Y. (2026) · JACC: Advances

Medication Adherence and ComplianceLipoproteins and Cardiovascular Health

Cited by 7